Transcriptomics

Dataset Information

0

An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cells [RNA-seq]


ABSTRACT: Interleukin-2 (IL-2) variants with increased CD25 dependence that selectively expand Foxp3+ regulatory T (TR) cells are in clinical trials for treating inflammatory diseases. Using an Fc-fused IL-2 mutein (Fc.IL-2 mutein) we developed that prevents diabetes in non-obese diabetic (NOD) mice, we show that Fc.IL-2 mutein induced an activated TR population with elevated proliferation, a transcriptional program associated with Stat5- and TCR-dependent gene modules, and high IL-10 and CTLA-4 expression. Increased IL-10 signaling limited surface MHC class II upregulation during conventional dendritic cell (cDC) maturation, while increased CTLA-4-dependent transendocytosis led to the transfer of CD80 and CD86 costimulatory ligands from maturing cDCs to TR cells. In NOD mice, Fc.IL-2 mutein treatment promoted the suppression of cDCs in the inflamed pancreas and pancreatic lymph nodes resulting in T cell anergy. Thus, IL-2 mutein-expanded TR cells have enhanced functional properties and restrict cDC function, offering promise for targeted immunotherapy use in autoimmune disease.

ORGANISM(S): Mus musculus

PROVIDER: GSE249186 | GEO | 2023/12/08

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-12-08 | GSE249481 | GEO
2022-04-07 | GSE200142 | GEO
| PRJNA1049360 | ENA
2013-02-14 | E-GEOD-27161 | biostudies-arrayexpress
2013-06-01 | E-GEOD-45679 | biostudies-arrayexpress
| PRJNA1047623 | ENA
2013-02-14 | GSE27161 | GEO
2013-06-01 | E-GEOD-45682 | biostudies-arrayexpress
| PRJNA1049369 | ENA
2021-07-13 | GSE160579 | GEO